EN DE

Zhejiang Qianjiang Biochemical Co (600796) Fair Value & Analysis

Basic Materials · CN · Market cap 4.4B CNY

ZQ Zhejiang Qianjiang Biochemical Co 600796 · SHG
Price¥5.04
Fair Value¥3.26
Upside-35.3%
Quality51/100
Watch Zhejiang Qianjiang Biochemical Co for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Solidly profitable · 10.6% net margin
Low debt · generates free cash flow
0.62% dividend yield
Trails peers (4/15)
Narrow moat 43/100
Evidence: Medium Range ¥2.17 – ¥4.08 Share as image

Fair value as of: Aug 9, 2026

From 25 valuation models · updated yesterday

Share price +7.5% over the past month.

A solid business, but screening 35% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥4.08). The favourable scenario is already priced in.
  • Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range (¥2.17 to ¥4.08) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥8.55 ¥3.81 Fair Value ¥3.26 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 9, 2026.

How to read this chart

60‑month range ¥3.81 – ¥8.55 · fair‑value band ¥2.17 – ¥4.08 · the ¥5.04 price screens above the ¥3.26 fair value. Dashed = 300-day average. As of Aug 9, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Zhejiang Qianjiang Biochemical Co (600796) currently trades at ¥5.04, while our model-based Fair Value estimate is ¥3.26, implying the stock looks roughly 35.3% overvalued today. The Quality Score stands at 51/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Zhejiang Qianjiang Biochemical Co generated revenue of 1.6B CNY at a net margin of 10.6%. Revenue declined 15.7% year over year. It earns a return on equity of 4.6%. Net debt stands at 633M CNY. Fundamentals as of Aug 9, 2026

Our scenario range runs from ¥2.17 (bear case) to ¥4.08 (bull case); at ¥5.04, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -35%, 600796 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥1.96 ¥3.60 ¥6.18 80
Residual Income ¥3.00 ¥3.03 ¥2.85 76
Rev-Margin DCF ¥1.67 ¥3.15 ¥5.03 74
All 25 models by family
DCF Models
FCF DCF ¥1.97 ¥3.75 ¥6.65 38
5Y Revenue Exit ¥1.67 ¥3.18 ¥5.19 39
5Y EBITDA Exit ¥2.62 ¥5.11 ¥8.19 41
5Y P/E Exit ¥1.82 ¥3.48 ¥5.34 38
10Y Revenue Exit ¥1.69 ¥3.12 ¥5.25 36
10Y EBITDA Exit ¥2.37 ¥4.49 ¥7.67 37
10Y P/E Exit ¥1.85 ¥3.34 ¥5.38 35
Earnings-Based
Graham-Dodd ¥1.31 ¥5.69 ¥7.79 54
Lynch FV ¥1.47 ¥2.09 ¥2.72 50
PEG = 1.0 ¥1.47 ¥2.09 ¥2.72 46
EPV ¥1.55 ¥1.87 ¥2.15 59
Dividend Discount
Gordon GGM ¥1.00 ¥1.98 ¥3.01 70
DDM Multi-Stage ¥1.00 ¥1.72 ¥2.09 61
Multiples
P/E Multiple ¥2.45 ¥3.26 ¥4.08 63
P/S Multiple ¥2.20 ¥2.93 ¥3.66 58
P/B Multiple ¥2.45 ¥3.26 ¥4.08 55
EV/EBIT ¥2.46 ¥3.44 ¥4.42 53
EV/EBITDA ¥3.28 ¥4.54 ¥5.80 54
EV/Revenue ¥1.56 ¥2.44 ¥3.32 43
Asset-Based
NCAV (Graham) ¥1.98 ¥2.66 ¥3.97 50
Growth DCF
Growth DCF ¥1.96 ¥3.60 ¥6.18 80
Rev-Margin DCF ¥1.67 ¥3.15 ¥5.03 74
Economic Profit
Residual Income ¥3.00 ¥3.03 ¥2.85 76
ROIC Compounder ¥1.55 ¥1.87 ¥2.15 72
Growth Earnings
Growth-Adj P/E ¥2.17 ¥3.10 ¥4.03 68

Widest divergence: DCF Models (¥3.48) versus Dividend Discount (¥1.72). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 1.6B CNY
Revenue growth (YoY) -15.7%
Net margin 10.6%
Return on equity 4.6%
Free cash flow 179M CNY FY2025
P/E ratio 26.9
More key figures
Operating margin 15.8%
EPS (TTM) ¥0.1900
Dividend yield 0.6%
Net debt 633M CNY FY2025

Figures from reported company fundamentals · as of Aug 9, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 51/100

Of which business quality 50 · Market factors (momentum, volatility) 35

Profitability 24
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 63
Earnings quality: real cash, not paper profit
Fin. Strength 42
Balance sheet, leverage, solvency risk
Investment 52
Disciplined investing over empire-building
Low Volatility 82
Calm price path (market factor)
Momentum 14
Price trend over the last 3–12 months (market factor)
52W Momentum 16
Distance to the 52-week high (market factor)
Net Issuance 90
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, research, develops, produces, sells, and services biopesticides in China and internationally.

Full company description

Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, research, develops, produces, sells, and services biopesticides in China and internationally. The company offers biopesticide products comprising plant growth regulators consisting of gibberellic acid and gibberellic acid A4+A7; insecticides, such as avermectin and emamectin benzoate; and fungicides, including jinggangmycin. It also provides ecological and environmental protection services, including the disposal and resource utilization of general solid and medical wastes, sludge, and kitchen waste, as well as sanitation and heat production services. In addition, the company offers water operation services comprising the protection and management of water environment; improvement of lakes and rivers; and investment, development, construction, operation, and management of water supply and drainage infrastructure, sewage treatment infrastructure, and related water projects. Further, it engages in the sale of steam; and construction installation activities. Zhejiang Qianjiang Biochemical Co., Ltd. was founded in 1970 and is headquartered in Haining, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Zhejiang Qianjiang Biochemical Co reported revenue of ¥1.7B in FY2025 versus ¥2.0B in FY2021, a compound −4.4%/yr. Reported net income was ¥166M in FY2025, compounding +3.0%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
1.7B CNY
Latest YoY
−4.2%
Avg. growth/yr (3Y)
−5.5%
Avg. growth/yr (5Y)
−2.2%
Avg. growth/yr (31Y)
+11.1%
Revenue −4.4%/yr
FY21 ¥2.0B
FY22 ¥2.0B
FY23 ¥2.0B
FY24 ¥1.8B
FY25 ¥1.7B
Net income +3.0%/yr
FY21 ¥148M
FY22 ¥206M
FY23 ¥211M
FY24 ¥160M
FY25 ¥166M

600796 screens 35% overvalued. Compare with Corteva, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Zhejiang Qianjiang Biochemical Co Fair Value". https://www.fairvalue-calculator.com/stock/600796

Peer Group

Agricultural Inputs · 179 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 51 · Below median
Fair Value upside −35% · Below median
Return on equity (TTM) 5% · Below median
Return on assets 2% · Below median
Net margin (TTM) 11% · Top 25%
Operating margin (TTM) 16% · Top 25%
Revenue growth -16% · Bottom 25%
Dividend yield (TTM) 0.6% · Below median
Debt / equity 0.41× · Higher than 75% of peers

Valuation Multiples vs Agricultural Inputs median · lower = cheaper

P/E (TTM) 26.5× · Pricier than median
P/B 1.27× · Cheaper than median
P/S (TTM) 2.67× · Pricier than 75% of peers
P/FCF 3.6× · Pricier than median
EV/EBITDA 12.2× · Pricier than 75% of peers
PEG 0.20× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 22
FUTURE 0 · sector 37
PAST 18 · sector 24
HEALTH 80 · sector 97
DIVIDEND 12 · sector 33

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 9, 2026).

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $86.07 $27.81 -68%
Nutrien Ltd NTR C$94.23 C$81.69 -13%
Qinghai Salt Lake Industry Co 000792 ¥24.93 ¥21.26 -15%
CF Industries Holdings CF $119.19 $161.00 +35%
SABIC Agri-Nutrients Company 2020 122.90 SAR 127.31 SAR +4%
Yara International ASA YAR kr 451.30 kr 67.25 -85%
Yunnan Yuntianhua Co 600096 ¥30.17 ¥42.12 +40%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥42.59 ¥38.01 -11%
Coromandel International Limited COROMANDEL ₹2,034 ₹1,129 -44%
UPL Limited UPL ₹594.75 ₹387.06 -35%

Compare Zhejiang Qianjiang Biochemical Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Zhejiang Qianjiang Biochemical Co (600796) overvalued or undervalued?
As of Aug 9, 2026, our model estimates a fair value of ¥3.26 versus a price of ¥5.04, about −35% (overvalued).
What is the fair value of 600796?
Our model-based fair value for Zhejiang Qianjiang Biochemical Co is ¥3.26 (as of Aug 9, 2026), built from audited fundamentals. The current price is ¥5.04.
What is the quality score of 600796?
Zhejiang Qianjiang Biochemical Co has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Zhejiang Qianjiang Biochemical Co (600796)?
Zhejiang Qianjiang Biochemical Co reported trailing-twelve-month revenue of about 1.6B CNY (latest available figure, as of Aug 9, 2026).
What is the net profit margin of 600796?
The net profit margin of Zhejiang Qianjiang Biochemical Co is about 10.6%, meaning it keeps roughly 10.6% of revenue as net income. Based on the latest reported figures.
Does Zhejiang Qianjiang Biochemical Co pay a dividend?
Zhejiang Qianjiang Biochemical Co currently shows a dividend yield of about 0.60% relative to its recent price (as of Aug 9, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Zhejiang Qianjiang Biochemical Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.